Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction. - England E; Rees DG; Scott IC; Carmen S; Chan DTY; Chaillan Huntington CE; Houslay KF; Erngren T; Penney M; Majithiya JB; Rapley L; Sims DA; et al. (Scientific reports, 2023)